MiSAM opposes bill giving $50 million in opioid settlement funds to ibogaine research
Alcoholism & Drug Abuse Weekly June 29, 2026 DOI: 10.1002/adaw.34965 via OpenAlex
Summary
AI-generated from the abstractThe Michigan Society of Addiction Medicine opposes a bill that would redirect opioid settlement funds toward research on ibogaine, a psychedelic drug, arguing that such funds should instead be used for evidence-based treatments for opioid use disorder.
Study at a glance
| Characteristics | Other Peer reviewed |
|---|---|
| Keywords | Settlement finance Legislature Opioid addiction Opioid abuse Bill of rights |
| Key finding | MiSAM opposes HB 6020, which would use opioid settlement funds for ibogaine research, favoring evidence-based treatments instead. |
Abstract
The Michigan Society of Addiction Medicine (MiSAM) has written a letter to the Michigan legislature opposing bill HB 6020, which would use opioid settlement funds to expand research into ibogaine.